BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19150605)

  • 1. Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma.
    Bello IO; Alanen K; Slootweg PJ; Salo T
    Oral Oncol; 2009 Sep; 45(9):760-5. PubMed ID: 19150605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizing regions and alpha-smooth muscle actin expression in a case of ameloblastic carcinoma.
    Kamath KP; Vidya M; Shetty N; Karkera BV; Jogi H
    Head Neck Pathol; 2010 Jun; 4(2):157-62. PubMed ID: 20333560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunohistochemical study of ameloblastoma and ameloblastic carcinoma.
    Yoon HJ; Jo BC; Shin WJ; Cho YA; Lee JI; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Dec; 112(6):767-76. PubMed ID: 22014999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proliferative markers in ameloblastomas and malignant odontogenic tumors.
    Otero D; Lourenço SQ; Ruiz-Ávila I; Bravo M; Sousa T; de Faria PA; González-Moles MA
    Oral Dis; 2013 May; 19(4):360-5. PubMed ID: 22970847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ameloblastic carcinoma ex ameloblastoma of the mandible with malignancy-associated hypercalcemia.
    Cox DP; Muller S; Carlson GW; Murray D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):716-22. PubMed ID: 11113817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of K6, K8, K16, K17, K19, maspin, syndecan-1 (CD138), α-SMA, and Ki-67 in ameloblastoma and ameloblastic carcinoma: diagnostic and prognostic correlations.
    Safadi RA; Quda BF; Hammad HM
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Apr; 121(4):402-11. PubMed ID: 26972539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression Profile of Stemness Markers CD138, Nestin and Alpha-SMA in Ameloblastic Tumours.
    Yiannis C; Mascolo M; Mignogna MD; Varricchio S; Natella V; De Rosa G; Lo Giudice R; Galletti C; Paolini R; Celentano A
    Int J Environ Res Public Health; 2021 Apr; 18(8):. PubMed ID: 33917771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameloblastic carcinoma, secondary type: a case report.
    Karakida K; Aoki T; Sakamoto H; Takahashi M; Akamatsu T; Ogura G; Sekido Y; Ota Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Dec; 110(6):e33-7. PubMed ID: 21112523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ameloblastic carcinoma and malignant amelobastoma: histological reunderstanding].
    Zhou Z; Lu Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 May; 32(3):169-71. PubMed ID: 10680531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ameloblastoma of the jaws.
    Munir M
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():261-7. PubMed ID: 10895162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of neural tissue markers (neuron-specific enolase, glial fibrillary acidic protein, S100 protein) in ameloblastic fibrodentinoma: a comparative study with ameloblastic fibroma.
    Takeda Y; Sato H; Satoh M; Nakamura SI; Yamamoto H
    Pathol Int; 2000 Aug; 50(8):610-5. PubMed ID: 10972858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch signaling in benign and malignant ameloblastic neoplasms.
    Nakano K; Siar CH; Tsujigiwa H; Nagatsuka H; Nagai N; Kawakami T
    Eur J Med Res; 2008 Oct; 13(10):476-80. PubMed ID: 19008176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy of ameloblastoma and ameloblastic carcinoma of the jaws. Analysis by image and flow cytometry.
    Müller S; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Nov; 117(11):1126-31. PubMed ID: 8239934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameloblastic carcinoma: a clinicopathologic study and assessment of eight cases.
    Corio RL; Goldblatt LI; Edwards PA; Hartman KS
    Oral Surg Oral Med Oral Pathol; 1987 Nov; 64(5):570-6. PubMed ID: 3313152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameloblastic carcinoma: report of an aggressive case with multiple bony metastases.
    Datta R; Winston JS; Diaz-Reyes G; Loree TR; Myers L; Kuriakose MA; Rigual NR; Hicks WL
    Am J Otolaryngol; 2003; 24(1):64-9. PubMed ID: 12579485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA content and clinicopathological features aid in distinguishing ameloblastic carcinoma from ameloblastoma.
    Penafort PVM; Rocha AC; Mariano FV; Dos Santos JN; Oliveira MC; Vargas PA; Sperandio M
    J Oral Pathol Med; 2024 Jan; 53(1):70-78. PubMed ID: 38163857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameloblastic carcinoma: case report and literature review.
    Avon SL; McComb J; Clokie C
    J Can Dent Assoc; 2003 Oct; 69(9):573-6. PubMed ID: 14653932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma.
    Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; de Almeida OP; Carrasco-Daza D; Farfán-Morales JE; Molina-Frechero N; Damián-Matsumura P
    Pathol Int; 2009 Apr; 59(4):229-33. PubMed ID: 19351365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of p16 tumor-suppressor gene in ameloblastic carcinoma, ameloblastoma, and dental follicles.
    Khojasteh A; Khodayari A; Rahimi F; Ghaderian MH; Jafarian M; Nayebi A; Akbarzadeh Najar R; Tabatabayipanah A; Jahangirnia A
    J Oral Maxillofac Surg; 2013 Jan; 71(1):62-5. PubMed ID: 22705216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ameloblastic carcinoma ex ameloblastoma: report of a case-possible involvement of CpG island hypermethylation of the p16 gene in malignant transformation.
    Abiko Y; Nagayasu H; Takeshima M; Yamazaki M; Nishimura M; Kusano K; Kitajo H; Saitoh M; Kawakami T; Chiba I; Kaku T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jan; 103(1):72-6. PubMed ID: 17178497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.